Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+early breast cancer

  • Ahn, H. K.; 
  • Park, K.; 
  • Sim, S. H.; 
  • Suh, K. J.; 
  • Kim, M. H.; 
  • 외 5명
Citations

WEB OF SCIENCE

0
제목
Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+early breast cancer
저자
Ahn, H. K.; Park, K.; Sim, S. H.; Suh, K. J.; Kim, M. H.; Park, W-Y.; Choi, Y-L.; Im, S-A.; Jung, K. H.; Park, Y. H.
DOI
10.1016/j.annonc.2022.03.020
발행일
2022-05
유형
Meeting Abstract
저널명
Annals of Oncology
권
33
페이지
S125 ~ S126